HPV-based cervical screening: from implementation to future possibilities

Sponsored by: Abbott Molecular Diagnostic

Speaker

David Hawkes, PhD

Director of Molecular Biology and Biochemistry at the Victorian Cytology Service
BIOGRAPHY

Event Date & Time

DATE: May 8, 2019

TIME: 9:00am CEST, 5:00pm (GMT+10)

Abstract

In 2017 the first national cervical screening programs using human papillomavirus (HPV-based) primary screening were implemented. As these programs have been implanted and developed further a number of questions have become apparent:

with over 300 HPV tests available which ones are suitable for use in a screening program
what is an appropriate quality framework for these tests
how can self-collection fit into cervical screening programs
HPV extended typing – how can this information be used in support of the current evidence base on cervical disease risk

These and other questions relating to the use of HPV testing in cervical screening programs will be covered using data from the Australian National Cervical Screening Program and other sources.

Key Learning Objectives:

Understand how to use the most effective HPV tests in a cervical cancer screening program
Understand how HPV self-collection sample type is becoming more critical in cervical cancer screening programs
Understand the utility and potential clinical benefits of extended HPV genotyping

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.